| 15-Jun-13 05:28PM | 3 Winners and 2 Losers From Rigel's Failure at Motley Fool |
| 08-Jun-13 12:10PM | This Week in Biotech at Motley Fool |
| 09:15AM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 05-Jun-13 04:45PM | AstraZeneca to Return Fostamatinib Rights Zacks |
| 07:40AM | Early Movers: AAPL, UNH, MSFT, TM & More at CNBC |
| 04-Jun-13 09:30PM | What's Ahead for Rigel Pharmaceuticals After This 18% Plunge? at Motley Fool -18.10% |
| 03:58PM | Stocks Slide on Fed Fears, Dow Ends Super Tuesday Streak Hot Stock Minute |
| 01:25PM | Why Rigel Pharmaceuticals Shares Were Shellacked at Motley Fool |
| 12:24PM | Arthritis drug setback for new AstraZeneca chief Pascal Soriot at Financial Times |
| 10:38AM | AstraZeneca Gives Up On Rigel's Arthritis Pill at Investor's Business Daily |
| 09:22AM | Stock Downgrades: Railing Against Canadian Pacific at Minyanville |
| 09:17AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:34AM | AstraZeneca returns treatment rights to Rigel AP |
| 07:32AM | Early Movers: AIG, DELL, DG, FDX, BWLD & More at CNBC |
| 07:02AM | Rigel Pharmaceuticals downgraded to Neutral from Overweight at Piper Jaffray at theflyonthewall.com |
| 06:45AM | AstraZeneca scraps Rigel arthritis pill in new R&D blow at Reuters |
| 05:41AM | Rigel announces fostamatinib OSKIRA-2, OSKIRA-3 study topline results theflyonthewall.com |
| 03:27AM | Rigel Will Resume Responsibility for Fostamatinib Program PR Newswire |
| 03:21AM | AstraZeneca Wont Seek Approval for Rigel Arthritis Drug at Bloomberg |
| 03:16AM | InPlay: Rigel Pharma and AstraZeneca (AZN) report topline results from OSKIRA-2 and OSKIRA-3; AZN will not proceed with filings, and return rights to Rigel Briefing.com |
| 02:15AM | AstraZeneca drops Rigel rheumatoid arthritis pill at Reuters |
| 02:00AM | Rigel Will Resume Responsibility for Fostamatinib Program PR Newswire |
| 22-May-13 07:30AM | Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye PR Newswire |
| 17-May-13 09:16AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 14-May-13 01:04PM | RIGEL PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 09-May-13 04:29PM | 3 Drug Catalysts to Watch in 2013 at Motley Fool |
| 07-May-13 09:08AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 07:30AM | Rigel Announces First Quarter 2013 Financial Results PR Newswire |
| 05:56AM | RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-May-13 08:00AM | April's Unhealthiest Stocks at Motley Fool |
| 03-May-13 04:25PM | Rigel Pharmaceuticals Becomes Oversold (RIGL) at TheStreet |
| 02-May-13 12:19AM | 3 Biggest Biotech Crashes in April at Motley Fool |
| 30-Apr-13 11:49AM | Expert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell Overseas Wall Street Transcript |
| 18-Apr-13 09:22PM | 5 Health Care Stocks Under $10 Ready to Rip Higher at TheStreet |
| 12-Apr-13 01:32PM | 5 Stocks Poised for Breakouts at TheStreet |
| 08-Apr-13 06:05PM | AZN Reports Data on Fostamatinib Zacks |
| 04:22PM | On The Fly: Closing Wrap theflyonthewall.com |
| 11:03AM | Small Pharma Watch List: Week Of April 8, 2013 at Seeking Alpha |
| 09:47AM | Why Rigel Is Poised to Bounce Back at Motley Fool |
| 09:02AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:00AM | Hot Stock Minute: Earnings Season Kicks Off; Nikkei Up, Up, and Away Hot Stock Minute |
| 06-Apr-13 12:30PM | This Week in Biotech at Motley Fool |
| 05-Apr-13 05:52PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool -40.24% |
| 04:22PM | On The Fly: Closing Wrap theflyonthewall.com |
| 01:12PM | Growing Aches and Pains Sink Rigel Pharmaceuticals at Motley Fool |
| 11:05AM | AstraZeneca Arthritis Drug Underperforms In Trial at Investor's Business Daily |
| 10:40AM | AstraZenecas Arthritis Pill Fails to Meet One End Goal in Late-Stage Trial at Fox Business |
| 10:19AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 09:48AM | UPDATE 3-AstraZeneca, Rigel arthritis pill disappoints again at Reuters |
| 09:00AM | On The Fly: Pre-market Movers theflyonthewall.com |
| 08:48AM | Rigel Sinks as Arthritis Medicine Shows Mixed Results at Bloomberg |
| 08:33AM | Government slowdown hammers F5 optionMONSTER |
| 08:33AM | F5 hammered by government slowdown optionMONSTER |
| 07:08AM | Rigel Pharmaceuticals downgraded to Market Perform from Outperform at BMO Capital theflyonthewall.com |
| 05:22AM | Astra, Rigel Arthritis Pill Posts Mixed Trial Results at TheStreet |
| 03:09AM | AstraZeneca Arthritis Medicine Has Mixed Results in Trial at Bloomberg |
| 02:51AM | UPDATE 1-AstraZeneca arthritis drug meets one of two study goals at Reuters |
| 02:01AM | AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis PR Newswire |
| 26-Mar-13 02:06PM | Pivotal Phase III Trial Data Ahead For 3 Development-Stage Small Pharma Companies at Seeking Alpha |
| 09-Mar-13 01:04PM | RIGEL PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 06-Mar-13 12:47PM | Loss at Rigel Narrower Than Expected Zacks +6.47% |
| 09:06AM | Company News for March 06, 2013 Zacks |
| 08:41AM | Rigel Pharmaceuticals: 7 Reasons To Buy This $7 Drug Stock at Seeking Alpha |
| 05-Mar-13 04:07PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 01:51PM | RIGEL PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 07:33AM | InPlay: Rigel Pharma beats by $0.02 Briefing.com |
| 07:30AM | Rigel Announces Fourth Quarter and Year End 2012 Financial Results PR Newswire |
| 28-Feb-13 07:30AM | Rigel Announces Participation at Two Investor Conferences PR Newswire |
| 19-Feb-13 10:55AM | Call strategy wagers on Rigel rebound optionMONSTER |
| 14-Feb-13 04:14PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online |
| 07-Feb-13 07:30AM | Rigel to Present at BIO CEO & Investor Conference PR Newswire |
| 13-Jan-13 02:26PM | JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals at Motley Fool |
| 07-Jan-13 09:37AM | 3 Health Care Companies I'm Watching Today at Motley Fool |
| 03-Jan-13 10:48AM | Snag RIGL 31.5% Lower Than Its Secondary? at Forbes |
| 07:37AM | Why Rigel Pharmaceuticals Lost Big in December at Motley Fool |
| 07:30AM | Rigel to Focus on Extensive Clinical Pipeline at Upcoming J.P. Morgan Presentation PR Newswire |
| 28-Dec-12 11:39AM | Molecular Diagnostic Based Therapies Create Defensive Fiscal Cliff Resistant Biotech Portfolio Strategy Wall Street Transcript |
| 21-Dec-12 11:05AM | 3 Stocks to Get on Your Watchlist at Motley Fool |
| 19-Dec-12 05:12PM | Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drug at Seeking Alpha |
| 17-Dec-12 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 01:22PM | Nasdaq stocks posting largest percentage increases AP |
| 09:35AM | This Week in Biotech at Motley Fool |
| 14-Dec-12 08:39PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool +18.33% |
| 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 05:09PM | AstraZeneca's RA Drug Disappoints Zacks |
| 02:32PM | Danaher Target Raised Following Investors Day and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 01:25PM | Nasdaq stocks posting largest percentage increases AP |
| 09:46AM | Danaher Target Raised Following Investors Day and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 09:42AM | Are these Biotech Stocks a Buy After Thursday's News? at Motley Fool |
| 08:35AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:52AM | Rigel Pharmaceuticals price target lowered to $10 from $15 at Oppenheimer theflyonthewall.com |
| 06:54AM | Why This Pharma Stock Tanked Yesterday at Motley Fool |
| 05:34AM | AstraZeneca rheumatoid arthritis drug disappoints at bizjournals.com |
| 13-Dec-12 05:43PM | Rigel dips on weak rheumatoid arthritis drug trial results at bizjournals.com -34.64% |
| 05:24PM | Good, Not Great, Isn't Good Enough at Motley Fool |
| 04:27PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 04:09PM | AstraZenecas Arthritis Drug Fails to Top Standard Therapy at Bloomberg |
| 03:44PM | Stocks Near Lows In Late Trading; Drug Stocks Sink at Investor's Business Daily |
| 02:15PM | Why Rigel Pharmaceuticals Shares Got Crushed at Motley Fool |
| 01:45PM | AstraZeneca falls as RA drug underperforms Humira AP |
